You are here

Found 14 results

Sort by:[Year][Author]
Filters: keyword is Nuclear Magnetic Resonanc  [Clear All Filters]
2007
Ortega RoldanJL, Romero RomeroML, OraA, AbE, LopezMayorga O, AzuagaAI, van NulandNA.  2007.  The high resolution NMR structure of the third SH3 domain of CD2AP. 39(4):331-336. Abstract
2006
SibilleN, FavierA, AzuagaAI, GanshawG, BottR, BonvinAM, BoelensR, van NulandNA.  2006.  Comparative NMR study on the impact of point mutations on protein stability of Pseudomonas mendocina lipase. 15(8):1915-1927. Abstract
TomaselliS, EspositoV, VangoneP, van NulandNA, BonvinAM, GuerriniR, TancrediT, TemussiPA, PiconeD.  2006.  The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. 7(2):257-267. Abstract
2005
DumoulinM, CanetD, LastAM, PardonE, ArcherDB, MuyldermansS, WynsL, MatagneA, RobinsonCV, RedfieldC, DobsonCM.  2005.  Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. Nature. 346(3):773-788. Abstract
2004
MessensJ, VanMolleI, VanhaesebrouckP, LimbourgM, VanBelle K, WahniK, MartinsJC, LorisR, WynsL.  2004.  How thioredoxin can reduce a buried disulphide bond. J. Mol. Biol.. 339(3):527-537. Abstract
CasaresS, SadqiM, Lopez-MayorgaO, Conejero-LaraF, van NulandNA.  2004.  Detection and characterization of partially unfolded oligomers of the SH3 domain of alpha-spectrin. 86(4):2403-2413. Abstract
2003
DerixNM, WechselbergerRW, van der HorstMA, HellingwerfKJ, BoelensR, KapteinR, van NulandNA.  2003.  Lack of negative charge in the E46Q mutant of photoactive yellow protein prevents partial unfolding of the blue-shifted intermediate. 42(49):14501-14506. Abstract
CanetD, LyonCE, ScheekRM, RobillardGT, DobsonCM, HorePJ, van NulandNA.  2003.  Rapid formation of non-native contacts during the folding of HPr revealed by real-time photo-CIDNP NMR and stopped-flow fluorescence experiments. 330(2):397-407. Abstract
MessensJ, MartinsJC, ZegersI, VanBelle K, BrosensE, WynsL.  2003.  Purification of an oxidation-sensitive enzyme, pI258 arsenate reductase from Staphylococcus aureus. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.. 790(1-2):217-227. Abstract
TzakosAG, BonvinAM, TroganisA, CordopatisP, AmzelML, GerothanassisIP, van NulandNA.  2003.  On the molecular basis of the recognition of angiotensin II (AII). NMR structure of AII in solution compared with the X-ray structure of AII bound to the mAb Fab131. 270(5):849-860. Abstract
2002
MessensJ, MartinsJC, VanBelle K, BrosensE, DesmyterA, DeGieter M, WieruszeskiJM, WillemR, WynsL, ZegersI.  2002.  All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascade. Proc. Natl. Acad. Sci. USA. 99(13):8506-8511. Abstract
HsuST, BreukinkE, deKruijff B, KapteinR, BonvinAM, van NulandNA.  2002.  Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles. 41(24):7670-7676. Abstract
2001
JacobsDM, MessensJ, WechselbergerRW, BrosensE, WillemR, WynsL, MartinJC.  2001.  1H, 13C and 15N backbone resonance assignment of the arsenate reductase from Staphylococcus aureus in its reduced state. J. Biomol. NMR. 20(1):95-96.
1999
Huyghues-DespointesBM, LanghorstU, SteyaertJ, PaceCN, ScholtzJM.  1999.  Hydrogen-exchange stabilities of RNase T1 and variants with buried and solvent-exposed Ala --> Gly mutations in the helix. Biochemistry. 38(50):16481-16490. Abstract

Publications on

Most recent publications